Marongiu F, Mulas G, Mamusa A M, Mameli G, Marassi P P, Tronci M B, Cambuli A B, Acca M R, Balestrieri A A
Istituto di Medicina Interna, Università di Cagliari, Italia.
Haemostasis. 1987;17(5):301-4. doi: 10.1159/000215759.
In order to investigate whether alpha 2-antiplasmin (alpha 2-AP) levels may be related to thrombin activity, we measured alpha 2-AP and fibrinopeptide A (FPA) in 51 patients with clinical conditions frequently associated with increased thrombin activity. The diagnoses were: atherosclerotic disease, chronic inflammatory disease and hematological neoplastic disease. A significant negative correlation was found between alpha 2-AP and FPA (p less than 0.01). When patients were divided into three subgroups on the basis of their FPA levels, a significant reduction in alpha 2-AP was found in patients with the highest FPA concentration (greater than 9 ng/ml). Accordingly, a significant negative relationship between alpha 2-AP and FPA was found only in this subgroup (p less than 0.01). Our data suggest that the partial consumption of alpha 2-AP in patients with elevated FPA levels may reflect a subclinical fibrinolysis activation secondary to increased thrombin activity.
为了研究α2 - 抗纤溶酶(α2 - AP)水平是否可能与凝血酶活性相关,我们在51例临床状况常与凝血酶活性增加相关的患者中测量了α2 - AP和纤维蛋白肽A(FPA)。诊断结果为:动脉粥样硬化疾病、慢性炎症性疾病和血液系统肿瘤性疾病。发现α2 - AP与FPA之间存在显著负相关(p < 0.01)。当根据FPA水平将患者分为三个亚组时,在FPA浓度最高(> 9 ng/ml)的患者中发现α2 - AP显著降低。因此,仅在该亚组中发现α2 - AP与FPA之间存在显著负相关(p < 0.01)。我们的数据表明,FPA水平升高患者中α2 - AP的部分消耗可能反映了继发于凝血酶活性增加的亚临床纤溶激活。